Recommended
December 23, 2024
2024 Recap: Top 8 Groundbreaking Innovations in Eye Disease Therapies and Technologies
The year 2024 has been a remarkable period for advancements in ophthalmology, with groundbreaking innovations reshaping the landscape of eye disease treatment and diagnosis.
Breaking News
FDA Approves Zeiss MEL 90 Excimer Laser for Refractive Surgery
Jan 14, 2025
The FDA has officially approved the Zeiss MEL 90 excimer laser for all three major indications: myopia, hyperopia, and mixed astigmatism.
FDA Accepts Revised Supplemental New Drug Application for IZERVAY
Jan 13, 2025
The U.S. Food and Drug Administration (FDA) has accepted a revised supplemental New Drug Application (sNDA) for IZERVAY (avacincaptad pegol intravitreal solution), a treatment for geographic atrophy (GA) secondary to age-related macular degeneration.
Alcon Recalls Systane Ultra PF Lot Over Potential Fungal Contamination
Dec 30, 2024
Alcon Laboratories has announced a voluntary recall of Lot 10101 of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count.
.jpg)
Industry News
Outlook Therapeutics Completes 12-Week Analysis of NORSE EIGHT Trial for ONS-5010 in Wet AMD
Jan 17, 2025
Outlook Therapeutics has finalized the analysis of 12-week safety and efficacy data from the NORSE EIGHT trial, which evaluated ONS-5010 as a treatment for wet age-related macular degeneration (AMD).
Prevent Blindness Receives Historic $9.7 Million Legacy Donation
Jan 17, 2025
Prevent Blindness, a leading organization dedicated to promoting eye health, announced it has received a landmark donation of $9.7 million from the Estate of Pamela Behrens, a Florida resident and longtime supporter.
Inflammasome Therapeutics Reports Promising Results from K8 Implant Trial for Geographic Atrophy
Jan 17, 2025
Inflammasome Therapeutics has announced encouraging 3-month topline results from a clinical trial evaluating its K8 implant for patients with geographic atrophy (GA).
Ophthalmic Research News
Microdrops Show Potential for Safer Retinopathy of Prematurity Screening in Preterm Infants
Jan 08, 2025
A study by Greek researchers has demonstrated that microdrops containing 1.67% phenylephrine and 0.33% tropicamide are not only effective but also safer alternatives to standard mydriatic eye drops used during ROP screenings in preterm infants.
OCT/OCTA Findings Reveal Neuroretinal Alterations in Fibromyalgia Patients
Jan 07, 2025
Turkish researchers have highlighted the role of optical coherence tomography (OCT) and OCT angiography (OCTA) in detecting neuroretinal changes in patients with fibromyalgia. These
AI-Driven Discovery Uncovers Potential Treatment for Acute Glaucoma
Jan 03, 2025
Acute glaucoma, characterized by retinal ganglion cell (RGC) death due to acute ocular hypertension, is a sight-threatening condition.
Ophthalmic Blog
2024 Recap: Top 8 Groundbreaking Innovations in Eye Disease Therapies and Technologies
Dec 23, 2024
The year 2024 has been a remarkable period for advancements in ophthalmology, with groundbreaking innovations reshaping the landscape of eye disease treatment and diagnosis.
2024 Recap: Top 8 FDA Approvals in Ophthalmology
Dec 16, 2024
The year 2024 has been a pivotal one for ophthalmology, with several novel FDA approvals introducing innovative treatments and technologies to the field
2024 Recap: Top 10 Breakthroughs in Ophthalmology Research
Dec 09, 2024
2024 has been a landmark year for breakthroughs in ophthalmology research, showcasing transformative advancements that are shaping the future of eye care.
Ophthalmology Breaking News Subscribe